test

Justin Hirsch

@Octagon Capital Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$642.902MTotal holdings41
Assets growth rate1.05%Assets growth rate (2-Q avg)-11.35%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Octagon Capital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Octagon Capital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 642.902M in assets, with a quarterly growth rate of 1.05% and a 2-quarter average growth rate of -11.35%. The portfolio is managed by Justin Hirsch, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
HLXBHelix Acquisition Corp Ii
Recent Activity
0.41%
$2.612M
250,000 shares@ $10.45 avg price
BDTXBlack Diamond Therapeutics I
Recent Activity
New Position
0.41%
$2.584M
594,000 shares@ $4.35 avg price
ANNXAnnexon Inc
Recent Activity
0.37%
$2.368M
400,000 shares@ $5.92 avg price
MRSNMersana Therapeutics Inc
Recent Activity
0.3%
$1.875M
992,000 shares@ $1.89 avg price
IPSCCentury Therapeutics Inc
Recent Activity
Decreased -50%
0.18%
$1.14M
666,825 shares@ $1.72 avg price
AVTEAerovate Therapeutics Inc
Recent Activity
0.16%
$972,770
465,440 shares@ $2.1 avg price
NUVB⤦Nuvation Bio Inc
Recent Activity
New Position
0.12%
$715,249
312,336 shares@ $2.29 avg price
AUTLAutolus Therapeutics Plc
Recent Activity
0.1%
$638,880
176,000 shares@ $3.63 avg price
NGNENeurogene Inc
Recent Activity
New Position
0.1%
$629,400
15,000 shares@ $41.96 avg price
RAPTRapt Therapeutics Inc
Recent Activity
0.1%
$586,920
292,000 shares@ $2.01 avg price